Novo Nordisk said the FDA is updating labeling for Victoza to include a clinical finding that the type 2 diabetes medicine is superior to Merck & Co.'s Januvia in terms of glucose control and weight loss. The label also reflects approved use of Victoza in combination with basal insulin.
Updated label touts Victoza's superiority for type 2 diabetes
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||